Health Care · Life Sciences Tools & Services
Agilent Technologies: revenue, profit and dividends
In fiscal 2025, Agilent Technologies had revenue of $6.95B, up 5.6% a year on average since 2015, and net income of $1.3B (18.8% of revenue). Its dividend per share has gone up 10 years in a row, to $0.99. It has 15% fewer shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +6.7% vs 2024
- Ticker
- A · NYSE
- Sector
- Health Care
- Sub-industry
- Life Sciences Tools & Services
- Headquarters
- Santa Clara, California
- Founded
- 1999
- In the S&P 500 since
- June 5, 2000
- Latest fiscal year
- 2025, ended October 31, 2025
- SEC filer
- Agilent Technologies, Inc. · CIK 0001090872
Revenue and net income
Revenue went from $5.42B in 2007 to $6.95B in 2025. Net loss in 2009.
Diluted earnings per share
Diluted EPS went from $1.57 in 2007 to $4.57 in 2025. Ten-year growth: 14.3% a year.
Dividends per share
Raised 10 years in a row, every year from 2016 to 2025. Ten-year growth: 9.5% a year.
Shares outstanding
14.9% fewer shares in 2025 than in 2015 (335M → 285M): buybacks outweighed new shares.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $1.15B in 2025, 16.6% of revenue.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Dividend | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $6.95B | $1.3B | 18.8% | $4.57 | $0.99 | 285M | $1.56B | $407M | $1.15B |
| 2024 | $6.51B | $1.29B | 19.8% | $4.43 | $0.94 | 291M | $1.75B | $378M | $1.37B |
| 2023 | $6.83B | $1.24B | 18.1% | $4.19 | $0.90 | 296M | $1.77B | $298M | $1.47B |
| 2022 | $6.85B | $1.25B | 18.3% | $4.18 | $0.84 | 300M | $1.31B | $291M | $1.02B |
| 2021 | $6.32B | $1.21B | 19.1% | $3.94 | $0.78 | 307M | $1.49B | $188M | $1.3B |
| 2020 | $5.34B | $719M | 13.5% | $2.30 | $0.72 | 312M | $921M | $119M | $802M |
| 2019 | $5.16B | $1.07B | 20.7% | $3.37 | $0.66 | 318M | $1.02B | $155M | $866M |
| 2018 | $4.91B | $316M | 6.4% | $0.97 | $0.60 | 325M | $1.09B | $177M | $910M |
| 2017 | $4.47B | $684M | 15.3% | $2.10 | $0.53 | 326M | $889M | $176M | $713M |
| 2016 | $4.2B | $462M | 11.0% | $1.40 | $0.46 | 329M | $793M | $139M | $654M |
| 2015 | $4.04B | $401M | 9.9% | $1.20 | $0.40 | 335M | $512M | $98M | $414M |
| 2014 | $4.05B | $549M | 13.6% | $1.62 | $0.53 | 338M | $731M | $205M | $526M |
| 2013 | $3.89B | $734M | 18.8% | $2.13 | $0.46 | 345M | $1.15B | $195M | $957M |
| 2012 | $6.86B | $1.15B | 16.8% | $3.27 | $0.30 | 353M | $1.23B | $194M | $1.03B |
| 2011 | $6.62B | $1.01B | 15.3% | $2.85 | $0.00 | 355M | $1.26B | $188M | $1.07B |
| 2010 | $5.44B | $684M | 12.6% | $1.94 | $0.00 | 353M | $718M | $121M | $597M |
| 2009 | $4.48B | −$31M | −0.7% | −$0.09 | — | 346M | $408M | $128M | $280M |
| 2008 | $5.77B | $693M | 12.0% | $1.87 | — | 371M | $756M | $154M | $602M |
| 2007 | $5.42B | $638M | 11.8% | $1.57 | — | — | $969M | $154M | $815M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
About these figures
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Life Sciences Tools & Services companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.